Our Portfolio Companies
We work closely with leading entrepreneurs to round out their business and professional strengths; take bold, constant strides towards their vision; and build something of lasting value.
Apreo Health
Apreo Health is dedicated to pioneering safe, transformative solutions for lung disease.
STAGE:
Venture
PARTNER:
Avalyn
Developing inhaled therapies to treat people with severe respiratory disease.
STAGE:
Venture
Callio Therapeutics
Callio Therapeutics is developing next‐generation dual‐payload antibody drug conjugates (ADCs) for various cancers.
STAGE:
Venture
PARTNERS:
ClearDATA
STAGE:
Venture
PARTNER:
Clever Care Health Plan
Delivering affordable and innovative Medicare Advantage health plans.
STAGE:
Venture
PARTNER:
Cytovale
Medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases.
STAGE:
Venture
PARTNER:
E2
Endovascular Engineering (“E2”) is a mission-driven company focused on the development and deployment of next generation clot removal technologies that target venous thromboembolism.
STAGE:
Venture
PARTNER:
Elligo Health Research
Connecting life sciences companies with physicians, patients, and data to accelerate clinical trials.
STAGE:
Growth Equity
PARTNER:
Engrail Therapeutics
A clinical-stage pharmaceutical company with the aspiration of becoming a leader in neuroscience.
STAGE:
Venture
PARTNER:
Excision BioTherapeutics
Developing CRISPR-based therapies to cure viral infectious diseases.
STAGE:
Venture
Galvanize Therapeutics
Galvanize Therapeutics is a leader in energy-based medical device technology that impacts biologic processes.
STAGE:
Venture
PARTNER:
HighFive Healthcare
Provider of endodontics and oral surgery services with locations across the Southern US.
STAGE:
Growth Equity
PARTNER:
Infinx
Intelligent payment lifecycle solutions for healthcare providers.
STAGE:
Growth Equity
PARTNER:
Kyo
Provider of Applied Behavioral Analysis (ABA) services for children w/ autism spectrum disorder (ASD).
STAGE:
Growth Equity
PARTNER:
MBX Biosciences
Improving the treatment of endocrine disorders through transformative peptide therapeutics.
STAGE:
Venture
PARTNER:
Mindful Health Solutions
Comprehensive mental health services for patients with anxiety, depression, and other conditions.
STAGE:
Growth Equity
PARTNER:
Monogram Health
Leading multispecialty provider of in-home, evidence-based care for polychronic patients.
STAGE:
Venture
PARTNER:
Mosanna Therapeutics
Improving the lives of patients with metabolic obstructive sleep apnea using a transformative approach.
STAGE:
Venture
PARTNERS:
Nectero Medical
Clinical-stage biotech company pioneering novel therapies to potentially treat aneurysmal disease.
STAGE:
Venture
PARTNER:
Onsite Dental
Bringing comprehensive dentistry directly to organizations and universities.
STAGE:
Growth Equity
PARTNER:
Ouro Medicines
Biotechnology company dedicated to developing immune reset therapeutics for people living with chronic immune-mediated diseases.
STAGE:
Venture
PARTNERS:
Ray Therapeutics
Developing novel optogenetic gene therapies for patients with blinding diseases.
STAGE:
Venture
PARTNER:
Regency Health
Provides specialized tertiary medical care services.
STAGE:
Venture
PARTNER:
Rezo Therapeutics
Pioneering the integrated mapping of disease networks for precision therapeutics.
STAGE:
Venture
PARTNER:
Route 92 Medical
Advancing neurovascular intervention.
STAGE:
Venture
PARTNER:
Scratch Financial
Scratch’s platform connects patients and medical providers in the care now, pay later economy.
STAGE:
Growth Equity
PARTNER:
SetPoint Medical
A novel device-based platform for the treatment of chronic autoimmune diseases like rheumatoid arthritis.
STAGE:
Venture
PARTNER:
ShiraTronics
ShiraTronics is a medtech innovator committed to transforming the lives of those living with Chronic Migraine.
STAGE:
Venture
PARTNER:
VenoStent
A clinical-stage medical device company developing a novel therapeutic device for improving dialysis patient outcomes.
STAGE:
Venture
PARTNER:
Zelis
STAGE:
Growth Equity
PARTNERS:
Zenas BioPharma
A biopharmaceutical company developing inflammation and immunology-directed therapies.
